About
Corporate Overview
Management
Scientific Advisory Board
Board of Directors
Board of Advisors
Partnerships
Pleadings
Technology
Technology Overview
Manufacturing
Intellectual Property
Publications
Clinical Pipeline
ACP-01 Phase II Clinical Trial for CLI
Platform
Critical Limb Ischemia
Investors
Investor Overview
A Three Minute Summary
Public Filings
AGM Materials
News & Media
News / Press Releases
Contact
MENU ≡
About
Corporate Overview
Management
Scientific Advisory Board
Board of Directors
Board of Advisors
Partnerships
Pleadings
Technology
Technology Overview
Manufacturing
Intellectual Property
Publications
Clinical Pipeline
ACP-01 Phase II Clinical Trial for CLI
Platform
Critical Limb Ischemia
Investors
Investor Overview
A Three Minute Summary
Public Filings
AGM Materials
News & Media
News / Press Releases
Contact
News & Media
all
2020
2019
2018
2017
2016
2015
2014
Nov 26
/ 2014
Hemostemix and Technical Ventures Complete RTO Transaction
Oct 02
/ 2014
Theravitae Inc. Announces Leadership Transition
Jun 25
/ 2014
Hemostemix Advances Clinical Trial Preparation
May 05
/ 2014
Hemostemix Joins Centre for Commercialization of Regenerative Medicine, Industry Consortium
Apr 22
/ 2014
Hemostemix Announces its Second US Patent
